Sertraline with methylphenidate in an ICU patient.
McGlohn
S E
SE
Bostwick
J M
JM
D015057:1-Naphthylamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000928:Antidepressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000008:administration & dosage* / Q000009:adverse effects; D003422:Critical Care / Q000523:psychology*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000523:psychology*; D008297:Male; D008774:Methylphenidate / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D011175:Positive-Pressure Respiration / Q000523:psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D020280:Sertraline
D015057:1-Naphthylamine; D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline